Medication info
Lyrica Extended-Release Tablets 150mg (Pregabalin)

Lyrica Extended-Release Tablets 150mg (Pregabalin)

Prescription medicationTablet
Ingredient · strength
Pregabalin›70mg / 1 tablet
Manufacturer / importer
Daewon Pharmaceutical Co., Ltd.
Appearance
White to pale yellow oblong film-coated extended-release tablets
Packaging
30 tablets (6 tablets/PTP x 5)
Approval status
Active

MFDS item code 201900143 · Approved 2019.01.11 · Insurance code 671806810

Summary

Main use
Treatment of peripheral neuropathic pain in adults
Who uses it
Adults · Children
Adult dosage
This medicine should be administered once daily after the evening meal. It should be swallowed whole and should not be split, crushed, or chewed. A starting dose of 150 mg per day may be administered. Based on each patient's response and tolerability, the dose may be increased at weekly intervals to a maximum of 600 mg per day. Based on current clinical experience, if treatment with this medicine is discontinued, it should be tapered gradually, with intervals of at least 1 week. The safety and efficacy of this medicine have not been established in patients with renal impairment. The safety and efficacy of this medicine have not been established in patients with hepatic impairment. The safety and efficacy of this medicine have not been established in older adults aged 65 years or older.
Children's dosage
Pediatric and adolescent patients under 19 years of age: The safety and efficacy of this medicine have not been established in pediatric and adolescent patients under 19 years of age.

Ingredients

Manufacturer
Daewon Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of peripheral neuropathic pain in adults

  • Peripheral neuropathic pain
View approved original text

This medication is used for the relief of pain caused by peripheral neuropathy in adults.

Dosage and Administration

Adult dosage

This medicine should be administered once daily after the evening meal. It should be swallowed whole and should not be split, crushed, or chewed. A starting dose of 150 mg per day may be administered. Based on each patient's response and tolerability, the dose may be increased at weekly intervals to a maximum of 600 mg per day. Based on current clinical experience, if treatment with this medicine is discontinued, it should be tapered gradually, with intervals of at least 1 week. The safety and efficacy of this medicine have not been established in patients with renal impairment. The safety and efficacy of this medicine have not been established in patients with hepatic impairment. The safety and efficacy of this medicine have not been established in older adults aged 65 years or older.

Children's dosage

Pediatric and adolescent patients under 19 years of age: The safety and efficacy of this medicine have not been established in pediatric and adolescent patients under 19 years of age.

Precautions

This medication may increase the risk of suicidal thoughts or behaviors; therefore, if there are any changes in mood or behavior during treatment, consult a healthcare professional immediately. Do not take if you are allergic to any of the components of this medication. Patients with diabetes should monitor and possibly adjust the dosage of blood sugar control medications due to potential weight gain. If serious allergic reactions such as angioedema occur, stop taking the medication immediately and inform a healthcare professional. Elderly patients should be cautious of the risk of falls due to dizziness or drowsiness and should avoid hazardous activities until accustomed to the drug effects. Consult a healthcare professional if any symptoms of visual disturbances or changes in vision occur. Do not abruptly discontinue this medication, as withdrawal symptoms such as insomnia, headache, nausea, and anxiety may occur; taper off gradually according to healthcare professional’s guidance. Patients with a history of substance abuse should be monitored closely for potential misuse of this medication. Patients with impaired kidney function may require dosage adjustments. Patients with heart disease should use caution when taking this medication. When used in combination with other central nervous system depressants, the risk of respiratory depression and other side effects may increase, so caution is advised. Early pregnancy may pose risks to the fetus; women who are pregnant or planning to become pregnant should consult a healthcare professional before use and effective contraception should be employed. Breastfeeding women should discuss the breastfeeding status with a healthcare professional as the drug may be transmitted in breast milk. It is safe to avoid performing hazardous tasks such as driving or operating machinery until any drowsiness or dizziness resolves after taking this medication. In case of overdose, symptoms such as confusion, drowsiness, and seizures may appear, and immediate emergency treatment is needed. Store this medication out of reach of children and do not transfer it to another container.

Side effects

  • Suicidal impulses
  • suicidal behavior
  • depression
  • abnormal changes in mood and behavior
  • angioedema
  • facial edema
  • perioral edema
  • upper respiratory tract edema
  • dizziness
  • drowsiness
Show 161 more
  • loss of consciousness
  • confusion
  • mental disorder
  • blurred vision
  • changes in vision
  • insomnia
  • headache
  • nausea
  • diarrhea
  • influenza-like syndrome
  • restlessness
  • pain
  • seizures
  • sweating
  • drug misuse
  • abuse
  • dependence
  • weight gain
  • constipation
  • dyspepsia
  • nausea
  • dry mouth
  • vomiting
  • peripheral edema
  • bradycardia
  • palpitations
  • itching
  • arthralgia
  • hypoglycemia
  • rhinitis
  • hypertension
  • blurred vision
  • double vision
  • vertigo
  • first-degree AV block
  • tachycardia
  • sinus bradycardia
  • hypotension
  • flushing
  • facial flushing
  • peripheral coldness
  • dyspnea
  • epistaxis
  • cough
  • nasal congestion
  • rhinitis
  • snoring
  • throat tension
  • nasal dryness
  • vomiting
  • abdominal bloating
  • distension
  • excessive salivation
  • gastroesophageal reflux disease
  • oral sensory impairment
  • ascites
  • dysphagia
  • pancreatitis
  • sweating
  • papular rash
  • urticaria
  • cold sweat
  • muscle cramps
  • back pain
  • limb pain
  • uterine contractions
  • joint swelling
  • myalgia
  • muscle spasm
  • neck pain
  • muscle rigidity
  • rhabdomyolysis
  • urinary disorders
  • urinary incontinence
  • reduced urination
  • renal failure
  • erectile dysfunction
  • delayed ejaculation
  • sexual dysfunction
  • dysmenorrhea
  • amenorrhea
  • mastalgia
  • nipple discharge
  • breast enlargement
  • gait abnormalities
  • falling
  • feeling of intoxication
  • sensory abnormalities
  • fatigue
  • chest tightness
  • generalized edema
  • pain
  • fever
  • chills
  • weakness
  • thirst
  • increased alanine aminotransferase
  • increased serum creatine phosphokinase
  • increased aspartate aminotransferase
  • increased blood sugar
  • decreased platelet count
  • decreased potassium levels
  • weight loss
  • increased serum creatinine
  • decreased white blood cell count
  • hypersensitivity
  • allergic reaction
  • headache
  • keratitis
  • congestive heart failure
  • pulmonary edema
  • tongue edema
  • toxic epidermal necrolysis
  • urinary retention
  • gynecomastia
  • lethargy
  • fatigue
  • weakness
  • gait abnormalities
  • decreased libido
  • sleep disturbance
  • insomnia
  • ataxia
  • speech disorders
  • sensory abnormalities
  • memory impairment
  • attention deficit
  • gastrointestinal disorders
  • bloody stools
  • increased BUN
  • dysuria
  • double vision
  • tinnitus
  • skin disorders
  • exacerbation of seizures
  • thalamic infarction
  • osteoarthritis
  • synovial cysts
  • anemia
  • oral perceptual disturbances
  • bruising
  • diabetic retinopathy
  • atrial fibrillation
  • heat sensation
  • sweating
  • thyroid nodule
  • spinal stenosis
  • musculoskeletal discomfort
  • limb discomfort
  • abdominal pain
  • epigastric pain
  • eyelid edema
  • cataracts
  • ear disorders
  • delirium
  • paralysis
  • facial paralysis
  • mood disorders
  • state of confusion
  • agitation
  • restlessness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect from air and moisture. The recommended storage temperature is between 1 to 30 degrees Celsius at room temperature. Proper storage will help maintain the effectiveness of the medication for a longer period.

Appearance and packaging

Appearance

White to pale yellow oblong film-coated extended-release tablets

Package unit

30 tablets (6 tablets/PTP x 5)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.